- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
München, Ludwig-Maximilians-Universität, Dissertation, 2017
- Keyword
-
Krebs
Onkologie
- Event
-
Veröffentlichung
- (where)
-
München
- (who)
-
Universitätsbibliothek der Ludwig-Maximilians-Universität
- (when)
-
2017
- Creator
- Contributor
-
Dreyling, Martin
- URN
-
urn:nbn:de:bvb:19-216921
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
25.03.2025, 1:48 PM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Bisling, Kathrin Eva
- Dreyling, Martin
- Universitätsbibliothek der Ludwig-Maximilians-Universität
Time of origin
- 2017
Other Objects (12)
Identification of CDX2 targets in acute myeloid leukaemia
TP53 mutations and drug sensitivity in acute myeloid leukaemia cells with acquired MDM2 inhibitor resistance
RUNX1 mutations in acute myeloid leukemia
Loss of heterozygosity in acute myeloid leukaemia with normal karyotype
Chemotherapy resistance-associated mutations in acute myeloid leukemia
Survivin’ acute Myeloid Leukaemia : a personalised target for inv(16) patients
Functional classification of TP53 mutations in acute myeloid leukemia
Characterization of the role of the CDX2 homeodomain in acute myeloid leukaemia
Development of an improved variant calling pipeline and the analysis of altered allelic transcription of recurrent mutations in Acute Myeloid Leukaemia
Functional characterisation of Enhancer of Zeste-Homologue 2 (EZH2) in acute myeloid leukaemia
Targeted siRNA carrier systems for the treatment of acute myeloid leukaemia (AML)
Single cell metabolic multiomics to identify vulnerabilities in acute myeloid leukaemia stem cells
Identification of CDX2 targets in acute myeloid leukaemia
TP53 mutations and drug sensitivity in acute myeloid leukaemia cells with acquired MDM2 inhibitor resistance
RUNX1 mutations in acute myeloid leukemia
Loss of heterozygosity in acute myeloid leukaemia with normal karyotype
Chemotherapy resistance-associated mutations in acute myeloid leukemia
Survivin’ acute Myeloid Leukaemia : a personalised target for inv(16) patients
Functional classification of TP53 mutations in acute myeloid leukemia
Characterization of the role of the CDX2 homeodomain in acute myeloid leukaemia
Development of an improved variant calling pipeline and the analysis of altered allelic transcription of recurrent mutations in Acute Myeloid Leukaemia
Functional characterisation of Enhancer of Zeste-Homologue 2 (EZH2) in acute myeloid leukaemia
Targeted siRNA carrier systems for the treatment of acute myeloid leukaemia (AML)
Single cell metabolic multiomics to identify vulnerabilities in acute myeloid leukaemia stem cells
Identification of CDX2 targets in acute myeloid leukaemia
TP53 mutations and drug sensitivity in acute myeloid leukaemia cells with acquired MDM2 inhibitor resistance
RUNX1 mutations in acute myeloid leukemia
Loss of heterozygosity in acute myeloid leukaemia with normal karyotype
Chemotherapy resistance-associated mutations in acute myeloid leukemia
Survivin’ acute Myeloid Leukaemia : a personalised target for inv(16) patients
Functional classification of TP53 mutations in acute myeloid leukemia
Characterization of the role of the CDX2 homeodomain in acute myeloid leukaemia
Development of an improved variant calling pipeline and the analysis of altered allelic transcription of recurrent mutations in Acute Myeloid Leukaemia
Functional characterisation of Enhancer of Zeste-Homologue 2 (EZH2) in acute myeloid leukaemia
Targeted siRNA carrier systems for the treatment of acute myeloid leukaemia (AML)